A Registered Cohort Study on Duchenne Muscular Dystrophy

Recruiting Observational Study
Duchenne Muscular Dystrophy
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
2 and older
Sex
Any
Study type
Observational
Participants needed
2,000 (estimated)
Sponsor
Ning Wang, MD., PhD. · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Dystrophinopathy is a term of X-linked recessive genetic disease, including Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and the X-linked dilated cardiomyopathy. The aim of this study is to determine the clinical spectrum and natural progression of dystrophinopathy in a prospective multicenter natural history study, to assess the clinical, genetic of patients with dystrophinopathy to op…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Beyond 2 years old * Diagnosis with Duchenne Muscular Dystrophy, and female carriers, genotypically confirmed * Diagnosis should be supported by muscle biopsy, if no genetic confirmation. Exclusion Criteria: * Presence of other clinically significant illness
Contacts

Ning Wang, MD, PhD

13805015340

ningwang@fjmu.edu.cn

CONTACT

Ming Jin, MD

Safariday@live.com

CONTACT